Jeffrey L. Cummings
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research 366
- Schizophrenia research and treatment 66
- Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments 68
- Physiology top 0.01%
- Alzheimer's disease research and treatments 274
- Cognitive Neuroscience top 0.01%
- Functional Brain Connectivity Studies 62
- Geriatrics and Gerontology top 0.01%
-
- Cholinesterase and Neurodegenerative Diseases 118
-
- Health Systems, Economic Evaluations, Quality of Life 81
-
- Computational Drug Discovery Methods 55
- Co-authors
- Ziad NasreddineNatalie A. PhillipsSimon CharbonneauIsabelle CollinHoward ChertkowVictor WhiteheadMichael S. MegaKate Zhong
- Journals
- New England Journal of Medicine (4 papers)Proceedings of the National Academy of Sciences (2 papers)The Lancet (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Jeffrey L. Cummings
961 papers receiving 100.5k citations
Hit Papers
Peers
Comparison fields: 5 of 228
- Psychiatry and Mental health 45.3k
- Neurology 11.8k
- Physiology 30.8k
- Cognitive Neuroscience 21.9k
- Geriatrics and Gerontology 4.2k
Countries citing papers authored by Jeffrey L. Cummings
This map shows the geographic impact of Jeffrey L. Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Cummings more than expected).
Fields of papers citing papers by Jeffrey L. Cummings
This network shows the impact of papers produced by Jeffrey L. Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Cummings. The network helps show where Jeffrey L. Cummings may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey L. Cummings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s diseasebreakdown → | 2025 | 40 |
| 3 | 2025 | 1 | |
| 4 | 2025 | 10 | |
| 5 | 2024 | 1 | |
| 6 | Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeuticsbreakdown → | 2023 | 145 |
| 7 | 2023 | 5 | |
| 8 | Genetic correlations between Alzheimer’s disease and gut microbiome generabreakdown → | 2023 | 95 |
| 9 | 2023 | 31 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 17 | |
| 12 | 2021 | 56 | |
| 13 | Developing the ATX(N) classification for use across the Alzheimer disease continuumbreakdown → | 2021 | 205 |
| 14 | Moving Beyond Coding: Why Secure Coding Should be Implemented | 2016 | 2 |
| 15 | 2008 | 1 | |
| 16 | 2007 | 1 | |
| 17 | Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon. | 2006 | 11 |
| 18 | 2006 | 207 | |
| 19 | 1999 | 22 | |
| 20 | The neuropsychiatry of limbic and subcortical disorders | 1997 | 70 |
About Jeffrey L. Cummings
Jeffrey L. Cummings is a scholar working on Psychiatry and Mental health, Physiology and Neurology, having authored 994 papers that have together received 104.0k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (366 papers), Alzheimer's disease research and treatments (274 papers), Cholinesterase and Neurodegenerative Diseases (118 papers), Health Systems, Economic Evaluations, Quality of Life (81 papers), Parkinson's Disease Mechanisms and Treatments (68 papers), Schizophrenia research and treatment (66 papers), Functional Brain Connectivity Studies (62 papers) and Computational Drug Discovery Methods (55 papers). The work is most often cited by research in Psychiatry and Mental health (45.3k citations), Neurology (11.8k citations) and Physiology (30.8k citations). Jeffrey L. Cummings has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ziad Nasreddine, Natalie A. Phillips, Simon Charbonneau, Isabelle Collin, Howard Chertkow, Victor Whitehead, Michael S. Mega, Kate Zhong, Jeffrey Gornbein and Susan Rosenberg-Thompson. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.